Detalhe da pesquisa
1.
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series.
Hepatology
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38478755
2.
Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C.
Hepatology
; 58(2): 497-504, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23300053
3.
Switching Vedolizumab from IV to SC Injection in Inflammatory Bowel Disease Patients with Active Disease: Real-World Experience from a German IBD Cohort.
J Clin Med
; 12(24)2023 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38137726
4.
Treating hepatitis D with bulevirtide - Real-world experience from 114 patients.
JHEP Rep
; 5(4): 100686, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37025462
5.
The Lipid Status in Patients with Ulcerative Colitis: Sphingolipids are Disease-Dependent Regulated.
J Clin Med
; 8(7)2019 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31277430
6.
Assessment of liver fibrosis with 2-D shear wave elastography in comparison to transient elastography and acoustic radiation force impulse imaging in patients with chronic liver disease.
Ultrasound Med Biol
; 41(9): 2350-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26116161
7.
Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).
PLoS One
; 10(2): e0117152, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25646622